Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127306861 | 12730686 | 1 | I | 20160829 | 20160910 | 20160910 | PER | US-ASTRAZENECA-2016SE92882 | ASTRAZENECA | 67.00 | YR | F | Y | 0.00000 | 20160910 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127306861 | 12730686 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 6132171971 | 21229 | 1 | DF | MODIFIED-RELEASE TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127306861 | 12730686 | 1 | Dyspepsia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127306861 | 12730686 | Condition aggravated | |
| 127306861 | 12730686 | Drug effect decreased | |
| 127306861 | 12730686 | Dyspepsia | |
| 127306861 | 12730686 | Product physical issue | |
| 127306861 | 12730686 | Reaction to drug excipients | |
| 127306861 | 12730686 | Suspected counterfeit product |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |